InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Legend Biotech Corp

LEGN Clue Score55
United States Fiscal year ends December CIK 0001801198
$18.62 -0.48% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $18.62 −67.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 5 Jun 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue49.1Net income−2.8EPS, diluted−0.01Fiscal year 2019Revenue60.0 +22.1%Net income−101.6EPS, diluted−0.51Fiscal year 2020Revenue75.0 +25.0%Net income−266.4EPS, diluted−1.13Fiscal year 2021Revenue68.8 −8.2%Net income−403.6EPS, diluted−1.43Fiscal year 2022Revenue117.0 +70.0%Net income−446.3EPS, diluted−1.40Fiscal year 2023Revenue285.1 +143.7%Operating income−528.1Net income−518.3EPS, diluted−1.47Fiscal year 2024Revenue627.2 +120.0%Operating income−309.5Net income−177.0EPS, diluted−0.48Fiscal year 2025Revenue1,028.9 +64.0%Operating income−136.5Net income−296.8EPS, diluted−0.81
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 49.1 60.0 75.0 68.8 117.0 285.1 627.2 1,028.9
Growth +22.1% +25.0% −8.2% +70.0% +143.7% +120.0% +64.0%
Operating income n/a n/a n/a n/a n/a −528.1 −309.5 −136.5
Net income −2.8 −101.6 −266.4 −403.6 −446.3 −518.3 −177.0 −296.8
Growth
EPS, diluted −0.01 −0.51 −1.13 −1.43 −1.40 −1.47 −0.48 −0.81
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Net margin−5.7%Free cash flow margin583.6%Fiscal year 2019Net margin−169.4%Free cash flow margin−183.1%Fiscal year 2020Net margin−355.2%Free cash flow margin−332.3%Fiscal year 2021Net margin−586.4%Free cash flow margin−349.7%Fiscal year 2022Net margin−381.5%Free cash flow margin−189.9%Fiscal year 2023Operating margin−185.2%Net margin−181.8%Free cash flow margin−145.0%Fiscal year 2024Operating margin−49.3%Net margin−28.2%Free cash flow margin−25.2%Fiscal year 2025Operating margin−13.3%Net margin−28.8%Free cash flow margin−12.5%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a −185.2% −49.3% −13.3%
Net margin −5.7% −169.4% −355.2% −586.4% −381.5% −181.8% −28.2% −28.8%
Free cash flow margin 583.6% −183.1% −332.3% −349.7% −189.9% −145.0% −25.2% −12.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow307.7Capital expenditure−21.0Free cash flow286.7Fiscal year 2019Operating cash flow−83.1Capital expenditure−26.8Free cash flow−109.8 −138.3%Fiscal year 2020Operating cash flow−223.0Capital expenditure−26.3Free cash flow−249.3Fiscal year 2021Operating cash flow−198.5Capital expenditure−42.2Free cash flow−240.7Fiscal year 2022Operating cash flow−201.3Capital expenditure−20.9Free cash flow−222.2Fiscal year 2023Operating cash flow−393.3Capital expenditure−20.1Free cash flow−413.4Fiscal year 2024Operating cash flow−144.0Capital expenditure−14.1Free cash flow−158.1Fiscal year 2025Operating cash flow−100.2Capital expenditure−28.6Free cash flow−128.8
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 307.7 −83.1 −223.0 −198.5 −201.3 −393.3 −144.0 −100.2
Capital expenditure −21.0 −26.8 −26.3 −42.2 −20.9 −20.1 −14.1 −28.6
Free cash flow 286.7 −109.8 −249.3 −240.7 −222.2 −413.4 −158.1 −128.8
Growth −138.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash210.2Shareholders’ equity252.9Fiscal year 2019Cash83.4Shareholders’ equity−122.9Fiscal year 2020Cash455.7Shareholders’ equity597.8Fiscal year 2021Cash688.9Total debt120.5Net cash (debt)568.5Shareholders’ equity765.9Debt to equity0.16Fiscal year 2022Cash786.0Total debt260.9Net cash (debt)525.1Shareholders’ equity744.3Debt to equity0.35Fiscal year 2023Cash1,277.7Total debt281.3Net cash (debt)996.4Shareholders’ equity1,251.4Debt to equity0.22Fiscal year 2024Cash286.7Total debt301.2Net cash (debt)−14.5Shareholders’ equity1,040.5Debt to equity0.29Fiscal year 2025Cash901.9Total debt0.0Net cash (debt)901.9Shareholders’ equity1,002.1Debt to equity0.00
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 210.2 83.4 455.7 688.9 786.0 1,277.7 286.7 901.9
Total debt n/a n/a n/a 120.5 260.9 281.3 301.2 0.0
Net cash (debt) n/a n/a n/a 568.5 525.1 996.4 −14.5 901.9
Shareholders’ equity 252.9 −122.9 597.8 765.9 744.3 1,251.4 1,040.5 1,002.1
Debt to equity n/a n/a n/a 0.16 0.35 0.22 0.29 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
307.7 −83.1 −223.0 −198.5 −201.3 −393.3 −144.0 −100.2
Growth −127.0%
Investment
−21.0 −26.8 −26.3 −42.2 −20.9 −20.1 −14.1 −28.6
calc 286.7 −109.8 −249.3 −240.7 −222.2 −413.4 −158.1 −128.8
Growth −138.3%
calc n/a n/a n/a n/a −0.70 −1.17 −0.43 −0.35
−102.3 −58.7 −24.2 −195.0 −77.1 92.9 −850.6 709.6
Financing
2.5 14.7 618.9 626.7 378.0 791.4 5.7 −0.3

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.